Case Study: Aesica Pharmaceuticals achieves accelerated Chinese serialization compliance and ERP upgrade with QAD

Aesica Pharmaceuticals - Customer Case Study

Aesica Pharmaceuticals, the Italian arm of contract development and manufacturing specialist Aesica Ltd, operates state-of-the-art facilities producing tablets, liquids and packaged pharmaceuticals for global markets, including a large China customer base. The company faced an urgent regulatory challenge when China’s serialization deadline was abruptly moved up from 12 months to just three, creating risk of substantial fines and potential loss of market access if they could not rapidly comply.

QAD and Aesica collaborated on a swift upgrade to QAD Enterprise Applications Enterprise Edition and deployed QAD’s new Serialization module, gaining corporate approval in three weeks and achieving compliance within the three‑month window. The result preserved Aesica’s Chinese revenue, consolidated their ERP and financial systems, and delivered end-to-end serialization and traceability capabilities that will be used across other markets.

Aesica Pharmaceuticals

Maurizio Beninati

IT Director